Telomerase reverse transcriptase catalytic subunit expression and proliferation index in Wilms tumor

Tumor Biology

Volumn 32, Issue 4, 2011, Pages 761-767

  Diniz, Gulden ^a   Aktas, Safiye ^b   Turedi, Aysen ^a   Temir, Gunyuz ^a   Ortac, Ragip ^a   Vergin, Canan ^a  

^a DR BEHÇET UZ CHILDREN'S HOSPITAL   (Turkey)

^b DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

hTERT expression; Ki67; Kidney; Oncology; Tumor biology

Indexed keywords

ANTINEOPLASTIC AGENT; KI 67 ANTIGEN; TELOMERASE REVERSE TRANSCRIPTASE; TELOMERASE REVERSE TRANSCRIPTASE CATALYTIC SUBUNIT; UNCLASSIFIED DRUG;

ARTICLE; CANCER STAGING; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; KIDNEY MASS; MALE; NEPHROBLASTOMA; ONCOLOGICAL PARAMETERS; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; PROLIFERATION INDEX; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SCHOOL CHILD; SURVIVAL RATE; SURVIVAL TIME; TUMOR VOLUME; TUMOR WEIGHT;

EID: 80052318431     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-011-0178-1     Document Type: Article

References (40)

1. Shay JW, Zou Y, Hiyama H, Wright WE. Telomerase and cancer. Hum mol genet. 2001;10(7):677-85. (Pubitemid 32331575)
2. Hiyama E, Yamaoka H, Matsunaga T, Hayashi Y, Ando H, Suita S, et al. High expression of telomerase is an independent prognostic indicator of poor outcome in hepatoblastoma. Br J Cancer. 2004;91(5):972-9. (Pubitemid 39273793)
3. Cukusić A, Skrobot Vidacek N, Sopta M, Rubelj I. Telomerase regulation at the crossroads of cell fate. Cytogenet Genome Res. 2008;122(3-4):263-72.
4. Cakir C, GulluogluMG, Yilmazbayhan D. Cell proliferation rate and telomerase activity in the differential diagnosis between benign and malignant mesothelial proliferations. Pathology. 2006;38(1):10-5. (Pubitemid 43259246)
5. Hiyama E, Hiyama K. Clinical utility of telomerase in cancer. Oncogene. 2002;21(4):643-9. (Pubitemid 34146266)
6. Hiyama E, Hiyama K,Yokoyama T, Shay JW. Immunohistochemical detection of telomerase (hTERT) protein in human cancer tissues and a subset of cells in normal tissues. Neoplasia. 2001;3(1):17-26. (Pubitemid 32201606)
7. Hashimoto Y, Murakami Y, Uemura K, Hayashidani Y, Sudo T, Ohge H, et al. Detection of human telomerase reverse transcriptase (hTERT) expression in tissue and pancreatic juice from pancreatic cancer. Surgery. 2008;143(1):113-25. (Pubitemid 350266038)
8. Bruey JM, Kantarjian H, Ma W, Estrov Z, Yeh C, Donahue A, et al. Circulating Ki-67 index in plasma as a biomarker and prognostic indicator in chronic lymphocytic leukemia. Leuk Res. 2010;34:1320-4.
9. Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol. 2000;182:311-22. (Pubitemid 30054364)
10. Jurić I, Pogorelić Z, Kuzmić-Prusac I, Biočić M, Jakovljević G, Stepan J, et al. Expression and prognostic value of the Ki-67 inWilms' tumor: experience with 48 cases. Pediatr Surg Int. 2010;26:487-93.
11. Scott RH, Walker L, Olsen ØE, Levitt G, Kenney I, Maher E, et al. Surveillance for Wilms tumour in at-risk children: pragmatic recommendations for best practice. Arch Dis Child. 2006;91(12):995-9. (Pubitemid 44863137)
12. Husain AN, Pysher TJ, Dehner LP. The kidney and lower urinary tract. In: Stocker JT, Dehner LP, editors. Pediatric pathology. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 834-903.
13. Perlman EJ. Renal tumors. In: Gilbert-Barness E, editor. Potter's pathology of the fetus, infant and child. Philadelphia: Mosby Elsevier; 2007. p. 1347-75.
14. Argani P, Beckwith JB. Renal neoplasms of childhood. In: Mills SE, editor. Sternberg's diagnostic surgical pathology. Philadelphia: Lippincott Williams and Wilkins; 2004. p. 2001- 33.
15. Metzger ML, Dome JS. Current therapy for Wilms' tumor. Oncologist. 2005;10(10):815-26. (Pubitemid 43152699)
16. Terenziani M, Spreafico F, Collini P, Piva L, Perotti D, Podda M, et al. Adult Wilms' tumor: a monoinstitutional experience and a review of the literature. Cancer. 2004;101(2):289-93. (Pubitemid 38890831)
17. Scott RH, Stiller CA, Walker L, Rahman N. Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour. J Med Genet. 2006;43(9):705-15. (Pubitemid 44483912)
18. Hohenstein P, Hastie ND. The many facets of the Wilms' tumour gene, WT1. Hum Mol Genet. 2006;15(Spec No 2):R196-201. (Pubitemid 44446794)
19. Maw MA, Grundy PE, Millow LJ, Eccles MR, Dunn RS, Smith PJ, et al. A third Wilms' tumor locus on chromosome 16q. Cancer Res. 1992;52(11):3094-8.
20. Rahman N, Arbour L, Tonin P, Renshaw J, Pelletier J, Baruchel S, et al. Evidence for a familial Wilms' tumour gene (FWT1) on chromosome 17q12-q21. Nat Genet. 1996;13(4):461-3. (Pubitemid 26256621)
21. Miozzo M, Perotti D, Minoletti F, Mondini P, Pilotti S, Luksch R, et al. Mapping of a putative tumor suppressor locus to proximal 7p in Wilms tumors. Genomics. 1996;37(3):310-5. (Pubitemid 26386955)
22. White GR, Kelsey AM, Varley JM, Birch JM. Somatic glypican 3 (GPC3) mutations in Wilms' tumour. Br J Cancer. 2002;86 (12):1920-2.
23. Rivera MN, Kim WJ, Wells J, Driscoll DR, Brannigan BW, Han M, et al. An X chromosome gene, WTX, is commonly inactivated in Wilms tumor. Science. 2007;315(5812):642-5. (Pubitemid 46214707)
24. Slade I, Stephens P, Douglas J, Barker K, Stebbings L, Abbaszadeh F, et al. Constitutional translocation breakpoint mapping by genome-wide paired-end sequencing identifies HACE1 as a putative Wilms tumour susceptibility gene. J Med Genet. 2010;47(5):342-7.
25. Ramachandran C, Melnick SJ, Escalon E, Jhabvala P, Khatib Z, Alamo A, et al. Expression of apoptosis, cell proliferation, and drug resistance genes in pediatric Wilms' tumors. Anticancer Res. 2000;20(5C):3759-65. (Pubitemid 32002272)
26. Ramburan A, Hadley GP, Govender D. Expression of E-cadherin, cadherin-11, alpha-, beta- and gamma-catenins in nephroblastomas: relationship with clinicopathological parameters, prognostic factors and outcome. Pathology. 2006;38(1):39-44. (Pubitemid 43259251)
27. Wittmann S, Wunder C, Zirn B, Furtwängler R, Wegert J, Graf N, et al. New prognostic markers revealed by evaluation of genes correlated with clinical parameters in Wilms tumors. Genes Chromosomes Cancer. 2008;47(5):386-95. (Pubitemid 351451793)
28. Dome JS, Chung S, Bergemann T, Umbricht CB, Saji M, Carey LA, et al. High telomerase reverse transcriptase (hTERT) messenger RNA level correlates with tumor recurrence in patients with favorable histology Wilms' tumor. Cancer Res. 1999;59 (17):4301-7. (Pubitemid 29418747)
29. Dome JS, Bockhold CA, Li SM, Baker SD, Green DM, Perlman EJ, et al. High telomerase RNA expression level is an adverse prognostic factor for favorable-histology Wilms' tumor. J Clin Oncol. 2005;23(36):9138-45.
30. Yashima K, Maitra A, Timmons CF, Rogers BB, Pinar H, Shay JW, et al. Expression of the RNA component of telomerase in Wilms tumor and nephrogenic rest recapitulates renal embryogenesis. Hum Pathol. 1998;29(5):536-42. (Pubitemid 28213476)
31. Green DM, D'Anjio GJ, Beckwith JB. Wilms' tumor. In: Pizzo PA, Fobcek DG, editors. Principles and practice of pediatric oncology. 2nd ed. Philadelphia: Lippincott; 1997. p. 733-59.
32. Williams G. Statistical methods. In: Detels R, Beaglehole R, Lansung MA, Gulliford M, editors. Oxford textbook of public health: epidemiological and biostatistical approaches, vol. 2. 5th ed. England: Oxford Press; 2009. p. 448-714.
33. Horster MF, Braun GS, Huber SM. Embryonic renal epithelia: induction, nephrogenesis, and cell differentiation. Physiol Rev. 1999;79:1157-91. (Pubitemid 29473314)
34. Quaggin SE, Kreidberg JA. Development of the renal glomerulus: good neighbors and good fences. Development. 2008;135(4):609-20. (Pubitemid 351405014)
35. Fischer EG, Carney JA, Anderson SR, Klatt EC, Lager DJ. An immunophenotypic comparison of metanephric metaplasia of Bowman capsular epithelium with metanephric adenoma, Wilms tumor, and renal development: a case report and review of the literature. Am J Clin Pathol. 2004;121(6):850-6. (Pubitemid 38669279)
36. Delahunt B, Farrant GJ, Bethwaite PB, Nacey JN, Lewis ME. Assessment of proliferative activity in Wilms' tumour. Anal Cell Pathol. 1994;7(2):127-38. (Pubitemid 24278676)
37. Berrebi D, Leclerc J, Schleiermacher G, Zaccaria I, Boccon- Gibod L, Fabre M, et al. High cyclin E staining index in blastemal, stromal or epithelial cells is correlated with tumor aggressiveness in patients with nephroblastoma. PLoS One. 2008;3(5):e2216.
38. Khine MM, Aung W, Sibbons PD, Howard CV, Clapham E, McGill F, et al. Analysis of relative proliferation rates of Wilms' tumor components using proliferating cell nuclear antigen and MIB-1 (Ki-67 equivalent antigen) immunostaining and assessment of mitotic index. Lab Invest. 1994;70(1):125-9. (Pubitemid 24080112)
39. Oh S, Song Y, Yim J, Kim TK. The Wilms' tumor 1 tumor suppressor gene represses transcription of the human telomerase reverse transcriptase gene. J Biol Chem. 1999;274 (52):37473-8.
40. Park JI, Venteicher AS, Hong JY, Choi J, Jun S, Shkreli M, et al. Telomerase modulates Wnt signalling by association with target gene chromatin. Nature. 2009;460(7251):66-72.